港股異動 | 中彙集團漲逾5%創新高 年度純利同比增34.1%至2.17億元
格隆匯11月6日丨中彙集團(0382.HK)今日低開高走,盤中觸及4.71港元創歷史新高,現報4.69港元,漲5.39%,暫成交1120萬港元,最新總市值47.8億港元。
中彙集團昨日盤後發佈截至8月31日止年度的年度業績稱,期內實現收入7.04億元(人民幣,下同),同比增10.7%;公司擁有人應占利潤2.17億元,同比增34.1%;每股基本盈利27.68分,擬派末期股息每股1港仙。收入增加主要原因是報告期內的在校學生人數及平均學費上升所致。
中信建投曾發研報指,中彙集團是大灣區最大民辦商科高教集團,地緣優勢顯著,新校區建設和盈利改善促增長,首次覆蓋給予“買入”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.